Zobrazeno 1 - 10
of 169
pro vyhledávání: '"R Maarten, Egeler"'
Autor:
Paul G. Kemps, Timo C. E. Zondag, Helga B. Arnardóttir, Nienke Solleveld-Westerink, Jelske Borst, Eline C. Steenwijk, Demi van Egmond, Joost F. Swennenhuis, Ellen Stelloo, Irene Trambusti, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Marijn A. Scheijde-Vermeulen, Marco J. Koudijs, Lenka Krsková, Cynthia Hawkins, R. Maarten Egeler, Jesper Brok, Tatiana von Bahr Greenwood, Karel Svojgr, Auke Beishuizen, Jan A. M. van Laar, Ulrike Pötschger, Caroline Hutter, Elena Sieni, Milen Minkov, Oussama Abla, Tom van Wezel, Cor van den Bos, Astrid G. S. van Halteren
Publikováno v:
Blood advances, 7(4), 664-679. American Society of Hematology
Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder caused by somatic genetic alterations in hematopoietic precursor cells differentiating into CD1a+/CD207+ histiocytes. LCH clinical manifestation is highly heterogeneous. BRAF and MAP2K
Autor:
Paul G. Kemps, Timo C. Zondag, Eline C. Steenwijk, Quirine Andriessen, Jelske Borst, Sandra Vloemans, Dave L. Roelen, Lenard M. Voortman, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Cynthia Hawkins, Veronica Lang, Arnoud H. de Ru, George M. C. Janssen, Geert W. Haasnoot, Kees L. M. C. Franken, Ronald van Eijk, Nienke Solleveld-Westerink, Tom van Wezel, R. Maarten Egeler, Auke Beishuizen, Jan A. M. van Laar, Oussama Abla, Cor van den Bos, Peter A. van Veelen, Astrid G. S. van Halteren
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Langerhans Cell Histiocytosis (LCH) is a neoplastic disorder of hematopoietic origin characterized by inflammatory lesions containing clonal histiocytes (LCH-cells) intermixed with various immune cells, including T cells. In 50–60% of LCH-patients,
Externí odkaz:
https://doaj.org/article/e72482c223694d18a86b7155b95eb24c
Autor:
Juan Carlos Fierro-Pineda, Hua-Ling Tsai, Amanda L Blackford, Andrew Cluster, Emi H Caywood, Jignesh Dalal, Jeffrey H Davis, R. Maarten Egeler, Jeffrey Huo, Michelle Hudspeth, Amy K. Keating, Susan S Kelly, Joerg Krueger, Dean A Lee, Leslie Elaine Lehmann, Lisa Madden, Benjamin R Oshrine, Michael A Pulsipher, Terry J Fry, Heather J Symons
Publikováno v:
Blood Advances.
Promising results have been reported for adult patients with high-risk hematologic malignancies undergoing haploidentical bone marrow transplant (haploBMT) with post-transplantation cyclophosphamide (PTCy). We report results from the first multicente
Autor:
Deepak Chellapandian, Polyzois Makras, Gregory Kaltsas, Cor van den Bos, Lamia Naccache, Raajit Rampal, Anne-Sophie Carret, Sheila Weitzman, R. Maarten Egeler, Oussama Abla
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 8, Iss 0, Pp e2016033-e2016033 (2016)
Background: Bone is the most common organ of involvement in patients with Langerhans cell histiocytosis (LCH), which is often painful and associated with significant morbidity from pathological fractures. Current first-line treatments include chemoth
Externí odkaz:
https://doaj.org/article/5735325a8e08420c8d23087bb62ca3e8
Autor:
Friso G.J. Calkoen, Carly Vervat, Else Eising, Lisanne S. Vijfhuizen, Peter-Bram A.C. ‘t Hoen, Marry M. van den Heuvel-Eibrink, R. Maarten Egeler, Maarten J.D. van Tol, Lynne M. Ball
Publikováno v:
Haematologica, Vol 100, Iss 11 (2015)
An aberrant interaction between hematopoietic stem cells and mesenchymal stromal cells has been linked to disease and shown to contribute to the pathophysiology of hematologic malignancies in murine models. Juvenile myelomonocytic leukemia is an aggr
Externí odkaz:
https://doaj.org/article/16effb71d68443fc904da1a113b797b8
Autor:
Hisaki Fujii, Zhi-Juan Luo, Hye Jin Kim, Susan Newbigging, Adam Gassas, Armand Keating, R Maarten Egeler
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133216 (2015)
Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2rγ-/- (NSG) mice are well des
Externí odkaz:
https://doaj.org/article/71cb522c128d4e9f809bc12a1934cf51
Autor:
Milen Minkov, Peter Beverley, Christopher K. Glass, Florent Ginhoux, Carl E. Allen, Eli L. Diamond, Astrid G. S. van Halteren, R. Maarten Egeler, Matthew Collin, Barrett J. Rollins
Publikováno v:
Nature Immunology, 21(1), 1-7. NATURE PUBLISHING GROUP
Progress in understanding the rare disease Langerhans cell histiocytosis has stimulated immersive meetings occurring annually over a 30-year period that bring together clinicians, scientists and patients in a unique collaboration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3476f3427c600543d0f0ec0f18bf2f6e
https://hdl.handle.net/1887/3181396
https://hdl.handle.net/1887/3181396
Autor:
Paul G, Kemps, Timo C, Zondag, Eline C, Steenwijk, Quirine, Andriessen, Jelske, Borst, Sandra, Vloemans, Dave L, Roelen, Lenard M, Voortman, Robert M, Verdijk, Carel J M, van Noesel, Arjen H G, Cleven, Cynthia, Hawkins, Veronica, Lang, Arnoud H, de Ru, George M C, Janssen, Geert W, Haasnoot, Kees L M C, Franken, Ronald, van Eijk, Nienke, Solleveld-Westerink, Tom, van Wezel, R Maarten, Egeler, Auke, Beishuizen, Jan A M, van Laar, Oussama, Abla, Cor, van den Bos, Peter A, van Veelen, Astrid G S, van Halteren
Publikováno v:
Frontiers in Immunology
Langerhans Cell Histiocytosis (LCH) is a neoplastic disorder of hematopoietic origin characterized by inflammatory lesions containing clonal histiocytes (LCH-cells) intermixed with various immune cells, including T cells. In 50–60% of LCH-patients,
Autor:
Paul G. Kemps, Timo C. Zondag, Eline C. Steenwijk, Quirine Andriessen, Jelske Borst, Sandra Vloemans, Dave L. Roelen, Lenard M. Voortman, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Cynthia Hawkins, Veronica Lang, Arnoud H. de Ru, George M. C. Janssen, Geert W. Haasnoot, Kees L. M. C. Franken, Ronald van Eijk, Nienke Solleveld-Westerink, Tom van Wezel, R. Maarten Egeler, Auke Beishuizen, Jan A. M. van Laar, Oussama Abla, Cor van den Bos, Peter A. van Veelen, Astrid G. S. van Halteren
Publikováno v:
Frontiers in Immunology, 10:3045. Frontiers Media S.A.
Frontiers in immunology, 10. Frontiers Media S.A.
Frontiers in Immunology, 10. FRONTIERS MEDIA SA
Frontiers in Immunology, Vol 10 (2020)
Frontiers in immunology, 10. Frontiers Media S.A.
Frontiers in Immunology, 10. FRONTIERS MEDIA SA
Frontiers in Immunology, Vol 10 (2020)
Langerhans Cell Histiocytosis (LCH) is a neoplastic disorder of hematopoietic origin characterized by inflammatory lesions containing clonal histiocytes (LCH-cells) intermixed with various immune cells, including T cells. In 50-60% of LCH-patients, t
Autor:
R. Maarten Egeler, Eli L. Diamond, Jan-Inge Henter, Robert Vassallo, Julien Haroche, Jean Donadieu, Sylvie Fraitag, Oussama Abla, Omar Abdel-Wahab, Frédéric Charlotte, Lawrence M. Weiss, AnnaCarin Horne, Abdellatif Tazi, Juana Gil Herrera, Jennifer Picarsic, Miriam Merad, Michael B. Jordan, Jean-François Emile, Carl E. Allen, Carlos Rodriguez-Galindo, Luis Requena-Caballero, Filip Janku, Barret J. Rollins, Alain Fischer
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide ra